On Oct 5, 2021 IOmx Therapeutics closed a Series B round and raised €65,000,000 from ATHOS Service, M Ventures, MIG, Sofinnova Partners, Wellington Partners, featuring […]
Grant – Benten Technologies
On Oct 1, 2021 Benten Technologies closed a Grant round and raised $3,500,000 from National Institutes of Health, featuring lead investors National Institutes of Health. […]
Series B – Expansion Therapeutics
On Sep 29, 2021 Expansion Therapeutics closed a Series B round and raised $80,000,000 from 5AM Ventures, Cormorant Asset Management, Kleiner Perkins, Logos Capital, Novartis […]
Series B – Expansion Therapeutics
On Sep 29, 2021 Expansion Therapeutics closed a Series B round and raised $80,000,000 from 5AM Ventures, Cormorant Asset Management, Kleiner Perkins, Logos Capital, Novartis […]
Post-IPO Equity – Oxford BioMedica
On Sep 22, 2021 Oxford BioMedica closed a Post-IPO Equity round and raised £50,000,000 from Serum Institute of India Pvt. Ltd., featuring lead investors Serum […]
Series B – Hexagon Bio
On Sep 22, 2021 Hexagon Bio closed a Series B round and raised $61,000,001 from 8VC, Casdin Capital, Nextech Invest, SoftBank Vision Fund, The Column […]
Series B – Hexagon Bio
On Sep 22, 2021 Hexagon Bio closed a Series B round and raised $61,000,001 from 8VC, Casdin Capital, Nextech Invest, SoftBank Vision Fund, The Column […]
Series B – Amolyt Pharma
On Sep 16, 2021 Amolyt Pharma closed a Series B round and raised $80,000,000 from Andera Partners, ATEM Capital, Bpifrance, Credit Agricole Entreprises, Eurazeo, Kurma […]
Series B – Amolyt Pharma
On Sep 16, 2021 Amolyt Pharma closed a Series B round and raised $80,000,000 from Andera Partners, ATEM Capital, Bpifrance, Credit Agricole Entreprises, Eurazeo, Kurma […]
Post-IPO Equity – Avalo Therapeutics
On Sep 14, 2021 Avalo Therapeutics closed a Post-IPO Equity round and raised $27,500,000 from investors, featuring lead investors . About the company: Avalo Therapeutics […]
